MicroPort Firebird 2 Registered Successfully in Uruguay

Shanghai, August 29, 2012--MicroPort Firebird2, Rapamycin-Eluting Coronary CoCr Stent System, received its first registration approval in Uruguay with validity of five years. Firebird2 is the sixth MicroPort product registered in the country after Firebird, Mustang, JIVE, Hercules-T, and Tango. Till now, Firebird2 has already received its medical product registration approval in nine countries.